GCIS
GlobalChemical Inventory Search
Abacavir mixture with lamivudine
阿巴卡韦,拉米呋啶混合物
,
阿巴卡韦,拉米夫定混合物, abacavir sulfate-lamivudine combination, Kivexa, abacavir,lamivudine drug combination, Epivir, ABC & 3TC, Abacavir sulfate and Lamivudine, [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol,4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
CAS Number: 852337-16-7
IUPAC name: [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
Molecular formula: C22H31N9O4S
Molecular weight: 517.60400
InChI: InChI=1S/C14H18N6O.C8H11N3O3S/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21;9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19);1-2,6-7,12H,3-4H2,(H2,9,10,13)/t8-,10+;6-,7+/m10/s1
InChIKey: UGWQMIXVUBLMAH-IVVFTGHFSA-N
SMILES: C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)[C@@H]4C[C@@H](C=C4)CO.C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
EINECS: -
One-Click Alert
Regions
Filter All
Category
Filter All
Sort
By key inventories
By listed

Focused on chemical complianceEmpowering the entire lifecycle of the chemical industry
Substance Information
CAS Number:
852337-16-7
Chemical Name:
Abacavir mixture with lamivudine
Chinese name:
阿巴卡韦拉米夫定
Date of inquiry :
Apr 22, 2026
Inquiry website:
https://www.chemradar.com/en/tools/gcisGCIS inquiry report
| Inventory Name | Country/Region | Status | Obligations |
|---|
ChemRadar
Global chemical compliance information, data and technical service platform
Service Hotline: +353 1 477 3710 (EU) +86 571 8720 6598 (CN) +81 70 9365 8022 (JP) +82 2 6347 8816 (KR)
Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
